Stocks. Options. A better conversation.

A stock market community
built for better research.

Research stocks and options with people who share your curiosity. Stock Market Chat combines a free trading Discord, market news, education, and proprietary research tools in one community.

Already a member? Open your market workspace

10,000+community members*
Stocks + optionsour market focus
Free to joinstart with the community
Built in-houseproprietary research tools

Research with more context

Different angles.
A better-informed view.

Explore company news, overnight price activity, options positioning, and valuation with research tools built by Stock Market Chat.

More than a signals server

Learn together.
Think for yourself.

Ask questions, compare perspectives, and understand the reasoning behind an idea. Bring your curiosity whether you are making your first watchlist or refining years of experience.

Get to know the community →
LEARN

Start with understanding.

Explore the learning center and discuss stocks, options, news, and risk with other members.

CONNECT

Keep the conversation going.

Follow market updates and customize the notifications that matter to you.

COMPETE

Put ideas into practice.

Join the stock market games, follow weekly and monthly rankings, and share the experience.

Find your place at SMC

Free to join. More to explore.

Start here

The free community

A place for traders and investors to learn, share perspectives, and follow the market together.

  • Stocks and options discussions
  • Education and community resources
  • Stock market games and leaderboards
  • Member website after Discord verification
Join Discord — free

Latest from SMC Research

Source-backed market news.

Read recent company developments with direct source links, clearly separated context, and visible uncertainty.

XRTX

XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout

XORTX Therapeutics announced an anticipated Clinical Trial Application planned for filing with Health Canada for XRx-026 (XORLO™), describing a two-part study XRX-OXY-102 that will evaluate their proprietary oxypurinol formulation in gout. The company says conducting part one in Canada is intended to support its planned NDA filing with the U.S. Food and Drug Administration.

· SMC Research

A few useful answers

Before you join.

Is Stock Market Chat free to join?

Yes. The Discord community is free to join. An optional Patreon membership provides advanced subscriber research and helps support SMC.

Where do I use the subscriber tools?

Subscriber market data, research outputs, and alerts are delivered in the Stock Market Chat Discord. Connect your Discord account to Patreon and complete the server's verification.

Can beginners join?

Absolutely. Start with the educational resources, ask questions, and learn through the community. You do not need to be an experienced trader.

How do I access the member website?

Join the Discord server and complete verification, then sign in with that same Discord account to access the member workspace.

Start with the community

Bring more context to your next conversation.

Join free. Get to know SMC. Explore advanced research when you are ready.